Pulmonary Venoocclusive Disease
نویسندگان
چکیده
منابع مشابه
Pulmonary venoocclusive disease and failure of specific therapy.
We read with interest the article in CHEST (June 2009) by Harch and colleagues,1 suggesting that pulmonary venoocclusive disease (PVOD) might be the main cause of the lack of response to specific therapy in patients with pulmonary arterial hypertension (PAH). The 80% rate of PVOD in patients with refractory PAH is higher than previously reported. Indeed, Dorfmüller et al2 have stated that PVOD ...
متن کاملMesenteric Inflammatory Venoocclusive Disease in a Patient with Sjögren's Syndrome
Mesenteric inflammatory venoocclusive disease is an uncommon cause of intestinal ischemia. Certain diseases, such as hypercoagulation disorders, autoimmune diseases, or drugs have been associated with the pathogenesis of mesenteric inflammatory venoocclusive disease. Here, we report a patient with Sjögren's syndrome who underwent surgery for suspected acute appendicitis with a subsequent pathol...
متن کاملStudy of an epidemic of venoocclusive disease in India.
Twenty-five cases of rapidly developing ascites occurring in an epidemic form were observed in a tribal district in Central India during August 1972-May 1973. Eleven of the patients died. Six patients were brought to hospital and studied for periods of two to 17 months. Necropsy was performed on one patient who died. The clinical features suggested an outflow tract obstruction such as a Budd-Ch...
متن کاملUrsodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.
haematologica vol. 87(10):october 2002 *University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; °Tarbiat Modarres University, School of Medical Sciences, Tehran, Iran; #Department of Clinical Chemistry, Municipal Hospital Rudolfstiftung, Vienna, Austria; @ViennaLab Labordiagnostika GmbH, Vienna, Austria Acknowledgments: we wish to thank A. Moritz, A. Tabarroki, E. Mehdipour, P. ...
متن کاملGlutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation.
Hepatic venoocclusive disease (HVOD) in bone marrow transplantation (BMT) is attributed to toxicity of cytoreductive agents, especially busulfan and cyclophosphamide, in the conditioning therapy. Busulfan, as well as the metabolites of cyclophosphamide, are conjugated with glutathione (GSH), catalyzed by enzymes of the glutathione S-transferase (GST) family. To assess the impact of polymorphism...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Annals of Thoracic Surgery
سال: 1976
ISSN: 0003-4975
DOI: 10.1016/s0003-4975(10)64911-9